# Rodabe N. Amaria

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rodabe-n-amaria/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,511 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 46 |
| i10-index | 103 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5029017725 |
| ORCID iD | https://orcid.org/0000-0001-6876-278X |
| Works | 319 |

## Researcher papers

- [Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy](https://scholariq.org/papers/loss-of-pten-promotes-resistance-to-t-cell-mediated-immunotherapy/)
- [Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma](https://scholariq.org/papers/neoadjuvant-immune-checkpoint-blockade-in-high-risk-resectable-melanoma/)
- [Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy](https://scholariq.org/papers/increased-tumor-glycolysis-characterizes-immune-resistance-to-adoptive-t-cell/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.